Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for ZYME

Stock Name	Zymeworks Inc. Common Stock
Ticker	ZYME(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	CA98985W1023

Show aggregate ZYME holdings

News associated with ZYME

Analysts Predict 13% Gains Ahead For ISCG: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:20
Citigroup Increases Zymeworks (NYSE:ZYME) Price Target to $22.00: Zymeworks (NYSE:ZYME – Get Free Report) had its price objective hoisted by Citigroup from $19.00 to $22.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 68.97% from the stock’s previous close. A […] - 2025-08-13 02:46:43
Zymeworks (NASDAQ:ZYME) Downgraded to Hold Rating by Wall Street Zen: Zymeworks (NASDAQ:ZYME – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday. Zymeworks Price Performance Shares of ZYME stock opened at $12.02 on Friday. The stock has a market cap of $837.55 million, a P/E ratio of […] - 2025-08-11 02:58:46
Cwm LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME): Cwm LLC increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1,091.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,299 shares of the company’s stock after acquiring an additional 2,106 shares during the quarter. Cwm LLC’s holdings in Zymeworks […] - 2025-08-06 04:27:03
Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Average Price Target from Analysts: Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-06-24 02:16:45
Ritholtz Wealth Management Decreases Holdings in Zymeworks Inc. (NYSE:ZYME): Ritholtz Wealth Management lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 18.8% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 60,494 shares of the company’s stock after selling 13,972 shares during the quarter. Ritholtz Wealth Management’s holdings in Zymeworks were worth $720,000 as of its most recent filing […] - 2025-06-19 05:00:55
Assenagon Asset Management S.A. Sells 147,184 Shares of Zymeworks Inc. (NYSE:ZYME): Assenagon Asset Management S.A. cut its position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 22.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 495,067 shares of the company’s stock after selling 147,184 shares during the quarter. Assenagon Asset Management S.A. […] - 2025-06-15 05:44:57
Public Employees Retirement System of Ohio Sells 10,400 Shares of Zymeworks Inc. (NYSE:ZYME): Public Employees Retirement System of Ohio lessened its stake in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 17.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 50,583 shares of the company’s stock after selling 10,400 shares during the period. Public Employees Retirement System of Ohio’s holdings in Zymeworks were worth $741,000 as […] - 2025-06-04 04:56:48
Nuveen Asset Management LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME): Nuveen Asset Management LLC boosted its stake in Zymeworks Inc. (NYSE:ZYME – Free Report) by 0.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 207,023 shares of the company’s stock after acquiring an additional 886 shares during the period. Nuveen Asset Management LLC’s holdings in Zymeworks were worth $3,031,000 at the end […] - 2025-06-03 04:53:06
Analysts Set Zymeworks Inc. (NYSE:ZYME) Target Price at $21.00: Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received an average rating of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-05-30 03:06:52
Zymeworks (NYSE:ZYME) Stock Price Up 4.2% After Insider Buying Activity: Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) shot up 4.2% during trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $12.22 and last traded at $12.32. 24,363 shares traded hands during trading, a decline of 96% from the average session volume of 596,591 shares. […] - 2025-05-22 02:32:57
Schonfeld Strategic Advisors LLC Invests $334,000 in Zymeworks Inc. (NYSE:ZYME): Schonfeld Strategic Advisors LLC purchased a new stake in Zymeworks Inc. (NYSE:ZYME – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,800 shares of the company’s stock, valued at approximately $334,000. A number of other […] - 2025-05-13 04:44:53
Barclays PLC Purchases 66,506 Shares of Zymeworks Inc. (NYSE:ZYME): Barclays PLC raised its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 43.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 220,890 shares of the company’s stock after purchasing an additional 66,506 shares during the quarter. Barclays PLC’s holdings in Zymeworks […] - 2025-04-29 05:22:53
Legal & General Group Plc Acquires 2,590 Shares of Zymeworks Inc. (NYSE:ZYME): Legal & General Group Plc increased its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 5.8% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 47,082 shares of the company’s stock after buying an additional 2,590 shares during the quarter. Legal & General Group Plc’s holdings […] - 2025-04-29 04:50:50
Russell Investments Group Ltd. Cuts Stake in Zymeworks Inc. (NYSE:ZYME): Russell Investments Group Ltd. reduced its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 9.7% during the fourth quarter, Holdings Channel reports. The fund owned 44,945 shares of the company’s stock after selling 4,826 shares during the period. Russell Investments Group Ltd.’s holdings in Zymeworks were worth $658,000 at the end of […] - 2025-04-23 05:20:54
Geode Capital Management LLC Reduces Stock Position in Zymeworks Inc. (NYSE:ZYME): Geode Capital Management LLC trimmed its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 3.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 689,884 shares of the company’s stock after selling 24,031 shares during the period. Geode Capital Management LLC’s holdings in Zymeworks were worth $10,100,000 as of its […] - 2025-04-23 04:27:03
Renaissance Technologies LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME): Renaissance Technologies LLC increased its holdings in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) by 54.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 285,700 shares of the company’s stock after buying an additional 101,100 shares during the quarter. Renaissance Technologies […] - 2025-04-22 05:04:52
XTX Topco Ltd Invests $493,000 in Zymeworks Inc. (NYSE:ZYME): XTX Topco Ltd acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 33,702 shares of the company’s stock, valued at approximately $493,000. Other hedge funds have also made changes to their positions in the […] - 2025-04-21 05:44:47
Federated Hermes Inc. Has $2.66 Million Holdings in Zymeworks Inc. (NYSE:ZYME): Federated Hermes Inc. grew its holdings in Zymeworks Inc. (NYSE:ZYME – Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 181,626 shares of the company’s stock after buying an additional 3,367 shares during the period. Federated […] - 2025-04-14 05:15:00
Zymeworks Inc. (NYSE:ZYME) Director Ecor1 Capital, Llc Purchases 196,438 Shares: Zymeworks Inc. (NYSE:ZYME – Get Free Report) Director Ecor1 Capital, Llc purchased 196,438 shares of the firm’s stock in a transaction that occurred on Friday, April 4th. The stock was acquired at an average price of $11.17 per share, with a total value of $2,194,212.46. Following the completion of the purchase, the director now owns […] - 2025-04-09 05:05:20
Zymeworks Inc. (NYSE:ZYME) Given Average Rating of “Moderate Buy” by Brokerages: Shares of Zymeworks Inc. (NYSE:ZYME – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating on […] - 2025-04-07 03:06:59
Schroder Investment Management Group Acquires New Shares in Zymeworks Inc. (NYSE:ZYME): Schroder Investment Management Group bought a new position in Zymeworks Inc. (NYSE:ZYME – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 337,161 shares of the company’s stock, valued at approximately $4,892,000. A number of other hedge funds have also added to […] - 2025-04-06 05:29:07
Zymeworks (NYSE:ZYME) Coverage Initiated by Analysts at Lifesci Capital: Lifesci Capital initiated coverage on shares of Zymeworks (NYSE:ZYME – Free Report) in a research note published on Tuesday,Benzinga reports. The brokerage issued an outperform rating and a $30.00 target price on the stock. A number of other research analysts have also recently commented on ZYME. JPMorgan Chase & Co. upgraded Zymeworks from a “neutral” […] - 2025-03-12 05:08:49
HC Wainwright Issues Positive Forecast for Zymeworks (NYSE:ZYME) Stock Price: Zymeworks (NYSE:ZYME – Free Report) had its target price raised by HC Wainwright from $12.00 to $13.00 in a research note issued to investors on Monday,Benzinga reports. HC Wainwright currently has a neutral rating on the stock. ZYME has been the topic of several other research reports. Wells Fargo & Company raised their price target […] - 2025-03-11 04:02:50
Citigroup Forecasts Strong Price Appreciation for Zymeworks (NYSE:ZYME) Stock: Zymeworks (NYSE:ZYME – Free Report) had its target price raised by Citigroup from $18.00 to $19.00 in a report released on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. A number of other research firms have also weighed in on ZYME. Wells Fargo & Company raised their target price on Zymeworks […] - 2025-03-10 04:44:48
New York State Common Retirement Fund Purchases 4,000 Shares of Zymeworks Inc. (NYSE:ZYME): New York State Common Retirement Fund lifted its position in Zymeworks Inc. (NYSE:ZYME – Free Report) by 42.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,371 shares of the company’s stock after buying an additional 4,000 shares during the period. […] - 2025-03-06 08:19:23
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Recommendation of “Moderate Buy” from Brokerages: Zymeworks Inc. (NYSE:ZYME – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 05:10:59

iShares Healthcare Innovation UCITS ETF USD (Acc) ZYME holdings

Date	Number of ZYME Shares Held	Base Market Value of ZYME Shares	Local Market Value of ZYME Shares	Change in ZYME Base Value	Current Price per ZYME Share Held	Previous Price per ZYME Share Held
2025-11-11 (Tuesday)	62,803	USD 1,235,963	USD 1,235,963	USD 102,369	USD 19.68	USD 18.05
2025-11-10 (Monday)	62,803	USD 1,133,594	USD 1,133,594	USD 99,857	USD 18.05	USD 16.46
2025-11-07 (Friday)	62,803	USD 1,033,737	USD 1,033,737	USD -90,437	USD 16.46	USD 17.9
2025-11-06 (Thursday)	62,803	USD 1,124,174	USD 1,124,174	USD -9,420	USD 17.9	USD 18.05
2025-11-05 (Wednesday)	62,803	USD 1,133,594	USD 1,133,594	USD -6,908	USD 18.05	USD 18.16
2025-11-04 (Tuesday)	62,803	USD 1,140,502	USD 1,140,502	USD -45,847	USD 18.16	USD 18.89
2025-11-03 (Monday)	62,803	USD 1,186,349	USD 1,186,349	USD -12,246	USD 18.89	USD 19.085
2025-10-31 (Friday)	62,803	USD 1,198,595	USD 1,198,595	USD -2,198	USD 19.085	USD 19.12
2025-10-30 (Thursday)	62,803	USD 1,200,793	USD 1,200,793	USD -16,329	USD 19.12	USD 19.38
2025-10-29 (Wednesday)	62,803	USD 1,217,122	USD 1,217,122	USD 5,024	USD 19.38	USD 19.3
2025-10-28 (Tuesday)	62,803	USD 1,212,098	USD 1,212,098	USD 52,127	USD 19.3	USD 18.47
2025-10-27 (Monday)	62,803	USD 1,159,971	USD 1,159,971	USD 45,846	USD 18.47	USD 17.74

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ZYME by Blackrock for IE00BYZK4776

Show aggregate share trades of ZYME

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -536 17.740 18.130 18.091 USD -9,697 13.57 Loss of -2,422 on sale
2025-09-11 BUY 271 16.320 16.360 16.356 USD 4,432 13.12
2025-07-08 SELL -269 12.950 13.250 13.220 USD -3,556 13.03 Loss of -52 on sale
2025-06-24 SELL -274 12.820 12.900 12.892 USD -3,532 13.04 Profit of 41 on sale
2025-06-23 SELL -274 12.470 12.520 12.515 USD -3,429 13.05 Profit of 146 on sale
2025-06-20 SELL -13,545 12.480 12.670 12.651 USD -171,358 13.05 Profit of 5,428 on sale
2025-06-11 SELL -327 12.880 13.220 13.186 USD -4,312 13.07 Loss of -37 on sale
2025-05-30 SELL -328 11.430 11.720 11.691 USD -3,835 13.13 Profit of 472 on sale
2025-05-21 BUY 327 11.940 12.740 12.660 USD 4,140 13.23
2025-05-14 SELL -1,956 11.250 11.730 11.682 USD -22,850 13.28 Profit of 3,131 on sale
2025-04-30 SELL -325 13.010 13.145 13.132 USD -4,268 13.40 Profit of 87 on sale
2025-04-28 SELL -326 12.880 12.980 12.970 USD -4,228 13.41 Profit of 144 on sale
2025-04-25 SELL -325 12.570 12.580 12.579 USD -4,088 13.42 Profit of 273 on sale
2025-04-11 SELL -1,998 10.630 10.730 10.720 USD -21,419 13.58 Profit of 5,714 on sale
2025-04-08 SELL -987 9.910 11.095 10.977 USD -10,834 13.71 Profit of 2,699 on sale
2025-04-07 SELL -710 10.430 10.745 10.713 USD -7,607 13.75 Profit of 2,155 on sale
2025-03-31 SELL -658 11.910 12.095 12.077 USD -7,946 13.85 Profit of 1,169 on sale
2025-03-21 SELL -654 12.720 13.030 12.999 USD -8,501 13.95 Profit of 622 on sale
2025-03-12 SELL -334 12.280 12.550 12.523 USD -4,183 14.09 Profit of 525 on sale
2025-02-28 SELL -332 13.400 13.690 13.661 USD -4,535 14.32 Profit of 219 on sale
2025-02-25 BUY 332 13.570 14.040 13.993 USD 4,646 14.36
2025-02-20 SELL -332 14.020 14.820 14.740 USD -4,894 14.37 Loss of -123 on sale
2025-02-19 BUY 662 14.820 14.820 14.820 USD 9,811 14.36
2025-02-18 BUY 331 14.670 15.250 15.192 USD 5,029 14.36
2024-12-30 SELL -632 14.510 14.680 14.663 USD -9,267 14.23 Loss of -271 on sale
2024-12-06 SELL -323 14.250 14.490 14.466 USD -4,673 14.31 Loss of -51 on sale
2024-12-04 SELL -323 14.110 14.340 14.317 USD -4,624 14.32 Profit of 1 on sale
2024-12-03 SELL -648 13.950 14.530 14.472 USD -9,378 14.33 Loss of -89 on sale
2024-11-21 SELL -330 13.680 15.000 14.868 USD -4,906 14.37 Loss of -163 on sale
2024-11-20 SELL -341 14.550 14.760 14.739 USD -5,026 14.36 Loss of -128 on sale
2024-11-19 SELL -340 14.770 14.970 14.950 USD -5,083 14.34 Loss of -207 on sale
2024-11-18 SELL -1,304 14.910 15.405 15.355 USD -20,024 14.31 Loss of -1,369 on sale
2024-11-12 SELL -326 17.400 17.700 17.670 USD -5,760 14.10 Loss of -1,164 on sale
2024-11-07 SELL -326 16.770 17.260 17.211 USD -5,611 13.70 Loss of -1,145 on sale
2024-11-05 SELL -652 14.660 14.860 14.840 USD -9,676 13.44 Loss of -914 on sale
2024-10-28 SELL -327 13.240 13.435 13.416 USD -4,387 13.05 Loss of -118 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-536	17.740	18.130	18.091	USD -9,697	13.57 Loss of -2,422 on sale
2025-09-11	BUY	271	16.320	16.360	16.356	USD 4,432	13.12
2025-07-08	SELL	-269	12.950	13.250	13.220	USD -3,556	13.03 Loss of -52 on sale
2025-06-24	SELL	-274	12.820	12.900	12.892	USD -3,532	13.04 Profit of 41 on sale
2025-06-23	SELL	-274	12.470	12.520	12.515	USD -3,429	13.05 Profit of 146 on sale
2025-06-20	SELL	-13,545	12.480	12.670	12.651	USD -171,358	13.05 Profit of 5,428 on sale
2025-06-11	SELL	-327	12.880	13.220	13.186	USD -4,312	13.07 Loss of -37 on sale
2025-05-30	SELL	-328	11.430	11.720	11.691	USD -3,835	13.13 Profit of 472 on sale
2025-05-21	BUY	327	11.940	12.740	12.660	USD 4,140	13.23
2025-05-14	SELL	-1,956	11.250	11.730	11.682	USD -22,850	13.28 Profit of 3,131 on sale
2025-04-30	SELL	-325	13.010	13.145	13.132	USD -4,268	13.40 Profit of 87 on sale
2025-04-28	SELL	-326	12.880	12.980	12.970	USD -4,228	13.41 Profit of 144 on sale
2025-04-25	SELL	-325	12.570	12.580	12.579	USD -4,088	13.42 Profit of 273 on sale
2025-04-11	SELL	-1,998	10.630	10.730	10.720	USD -21,419	13.58 Profit of 5,714 on sale
2025-04-08	SELL	-987	9.910	11.095	10.977	USD -10,834	13.71 Profit of 2,699 on sale
2025-04-07	SELL	-710	10.430	10.745	10.713	USD -7,607	13.75 Profit of 2,155 on sale
2025-03-31	SELL	-658	11.910	12.095	12.077	USD -7,946	13.85 Profit of 1,169 on sale
2025-03-21	SELL	-654	12.720	13.030	12.999	USD -8,501	13.95 Profit of 622 on sale
2025-03-12	SELL	-334	12.280	12.550	12.523	USD -4,183	14.09 Profit of 525 on sale
2025-02-28	SELL	-332	13.400	13.690	13.661	USD -4,535	14.32 Profit of 219 on sale
2025-02-25	BUY	332	13.570	14.040	13.993	USD 4,646	14.36
2025-02-20	SELL	-332	14.020	14.820	14.740	USD -4,894	14.37 Loss of -123 on sale
2025-02-19	BUY	662	14.820	14.820	14.820	USD 9,811	14.36
2025-02-18	BUY	331	14.670	15.250	15.192	USD 5,029	14.36
2024-12-30	SELL	-632	14.510	14.680	14.663	USD -9,267	14.23 Loss of -271 on sale
2024-12-06	SELL	-323	14.250	14.490	14.466	USD -4,673	14.31 Loss of -51 on sale
2024-12-04	SELL	-323	14.110	14.340	14.317	USD -4,624	14.32 Profit of 1 on sale
2024-12-03	SELL	-648	13.950	14.530	14.472	USD -9,378	14.33 Loss of -89 on sale
2024-11-21	SELL	-330	13.680	15.000	14.868	USD -4,906	14.37 Loss of -163 on sale
2024-11-20	SELL	-341	14.550	14.760	14.739	USD -5,026	14.36 Loss of -128 on sale
2024-11-19	SELL	-340	14.770	14.970	14.950	USD -5,083	14.34 Loss of -207 on sale
2024-11-18	SELL	-1,304	14.910	15.405	15.355	USD -20,024	14.31 Loss of -1,369 on sale
2024-11-12	SELL	-326	17.400	17.700	17.670	USD -5,760	14.10 Loss of -1,164 on sale
2024-11-07	SELL	-326	16.770	17.260	17.211	USD -5,611	13.70 Loss of -1,145 on sale
2024-11-05	SELL	-652	14.660	14.860	14.840	USD -9,676	13.44 Loss of -914 on sale
2024-10-28	SELL	-327	13.240	13.435	13.416	USD -4,387	13.05 Loss of -118 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ZYME

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	94,136	1,600	239,515	39.3%
2025-09-18	87,507	0	276,415	31.7%
2025-09-17	78,917	12	185,265	42.6%
2025-09-16	48,268	0	96,783	49.9%
2025-09-15	91,077	30	160,435	56.8%
2025-09-12	52,048	0	124,347	41.9%
2025-09-11	100,668	0	235,025	42.8%
2025-09-10	58,604	0	142,916	41.0%
2025-09-09	69,135	0	136,587	50.6%
2025-09-08	62,729	0	164,403	38.2%
2025-09-05	64,229	0	206,255	31.1%
2025-09-04	67,077	0	153,481	43.7%
2025-09-03	57,275	0	125,689	45.6%
2025-09-02	105,513	0	205,869	51.3%
2025-08-29	53,363	0	90,353	59.1%
2025-08-28	62,796	200	117,564	53.4%
2025-08-27	39,838	0	64,384	61.9%
2025-08-26	50,535	0	78,631	64.3%
2025-08-25	50,376	205	104,856	48.0%
2025-08-22	52,901	0	140,092	37.8%
2025-08-21	42,417	0	92,901	45.7%
2025-08-20	37,914	505	63,656	59.6%
2025-08-19	63,172	0	111,574	56.6%
2025-08-18	72,639	0	124,538	58.3%
2025-08-15	50,490	0	105,800	47.7%
2025-08-14	74,408	595	141,373	52.6%
2025-08-13	116,112	0	237,707	48.8%
2025-08-12	65,345	0	134,908	48.4%
2025-08-11	75,572	0	170,921	44.2%
2025-08-08	105,315	0	506,942	20.8%
2025-08-07	60,083	0	127,816	47.0%
2025-08-06	225,620	900	359,568	62.7%
2025-08-05	54,397	0	121,221	44.9%
2025-08-04	39,683	0	90,919	43.6%
2025-08-01	40,790	0	376,657	10.8%
2025-07-31	21,115	0	71,774	29.4%
2025-07-30	65,554	0	129,960	50.4%
2025-07-29	51,677	0	112,921	45.8%
2025-07-28	59,981	0	107,253	55.9%
2025-07-25	35,014	0	82,719	42.3%
2025-07-24	60,894	0	104,765	58.1%
2025-07-23	39,590	45	68,976	57.4%
2025-07-22	71,302	0	128,676	55.4%
2025-07-21	81,357	0	133,962	60.7%
2025-07-18	77,153	20	152,213	50.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE